Drug Conjugates for Targeting Regulatory T Cells in the Tumor Microenvironment: Guided Missiles for Cancer Treatment

Scientists discuss key themes and recent advances in drug conjugates targeting Tregs in the tumor microenvironment (TME), as well as future design strategies for successful use of drug conjugates for Treg targeting in immunotherapy.